Reaction
Sickle Cell Anaemia reporting signals
As of the last recalculation, Sickle Cell Anaemia appears in 643 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is DEFERASIROX (PRR 208.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Deferasirox | 135 | 208.3 | 209.4 |
| Hydroxyurea | 39 | 63.5 | 63.6 |
| Zidovudine | 20 | 49.9 | 50.0 |
| Voxelotor | 26 | 39.1 | 39.1 |
| Ambrisentan | 90 | 27.0 | 27.0 |
| Riociguat | 22 | 22.6 | 22.6 |
| Bosentan | 28 | 18.8 | 18.8 |
| Treprostinil | 56 | 15.7 | 15.7 |
| Patiromer | 4 | 9.4 | 9.4 |
| Aflibercept | 7 | 7.3 | 7.3 |